Man Group’s Astrana Health ASTH Stock Holding History

Man Group’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$865K	Sell	18,639 -134,739	-88%	-$4.85M	﹤0.01%	1902
2026 Q1	$3.76M	Buy	+153,378	New	+$3.63M	0.01%	1296
2022 Q4	–	Sell	-80,471	Closed	-$3.14M	–	2274
2022 Q3	$3.14M	Buy	+80,471	New	+$3.68M	0.01%	910
2022 Q2	–	Sell	-39,522	Closed	-$1.5M	–	1215
2022 Q1	$1.92M	Buy	39,522 +295	+0.8%	+$15.2K	0.01%	1225
2021 Q4	$2.88M	Buy	39,227 +5,006	+15%	+$411K	0.01%	1066
2021 Q3	$3.12M	Buy	+34,221	New	+$2.91M	0.01%	1028
2018 Q2	–	Sell	-26,086	Closed	-$416K	–	2252
2018 Q1	$416K	Buy	+26,086	New	+$540K	﹤0.01%	1759

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Man Group's ASTH Position: Q2 2026 in Review

Man Group reduced its Astrana Health (ASTH) stake by 88% in Q2 2026, selling an estimated $4.85M and leaving 18,639 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Man Group first reported a position in ASTH in Q1 2018 and has held it in 7 quarters since. The position peaked at $3.76M in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Man Group held 18,639 shares of Astrana Health worth $865K as of Q2 2026.
Man Group sold 134,739 Astrana Health shares in Q2 2026, an estimated $4.85M.
Astrana Health made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1902 holding.
Man Group first reported a position in Astrana Health in Q1 2018 and has held it in 7 quarters since.
Man Group's Astrana Health position peaked at $3.76M in Q1 2026.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.